Adaptive Optics (AO) Retinal Imaging System
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Division of Biomedical Physics (DBP) is conducting market research via a Sources Sought Notice to identify qualified sources for an Adaptive Optics (AO) Retinal Imaging System. This system will support ophthalmic research, including the development of regulatory science tools and standards for cellular-level ophthalmic imaging. Responses are due May 12, 2026, at 4:00 PM Eastern Time.
Purpose & Scope
The FDA requires a high-resolution Ophthalmic Adaptive Optics (AO) Retinal Imaging System. This system is crucial for ongoing studies focused on characterizing novel optical diagnostic devices for retinal diseases, developing biomarkers for early disease detection (e.g., glaucoma), and advancing regulatory science tools. The system must be a complete solution, including hardware, software, delivery, installation, and training, provided by a single contractor.
Key Requirements
- Hardware: Pupillary reflectance imaging, non-contact transscleral flood illumination, IR LED and SLD light sources (750-890 nm), 2-3 µm lateral resolution, 1 µm pixel pitch, 300 µm focusing range, >6.5° x 6.5° cellular view, 30° x 30° fundus overview, minimum 4 mm pupil diameter, +15 D to -15 D refractive error adjustment, <3s acquisition time, internal/external fixation targets.
- Software: Simultaneous live widefield overview and cellular-level imaging, pupil alignment feedback, image comparison for follow-up.
- Physical: Max dimensions 65x65x65 cm, max weight 60 kg, 100-240V, 50-60 Hz, max 450W power consumption.
- Support: Delivery to FDA White Oak Campus (Silver Spring, MD), user manuals, license keys, operator training, packaging, shipping, and a minimum one-year warranty.
- Compliance: All Electronic and Information Technology (EIT) must comply with Section 508 of the Rehabilitation Act. FDA CIO pre-approval is required for all IT hardware/software prior to award.
Submission Details
- Response Deadline: May 12, 2026, at 4:00 PM Eastern Time.
- Submission Method: Electronically via email to freshta.javid@fda.hhs.gov.
- Subject Line: Sources Sought Response — AO Retinal Imaging System — CDRH-2026-133666
- Requested Information: Firms should provide company details (CAGE, UEI, business size, GSA Schedule), technical capability (product description, datasheets, prior deliveries), delivery/installation capability (lead time, single contractor confirmation), Rough Order of Magnitude (ROM) pricing, and Section 508 compliance posture.
Additional Notes
This is a Sources Sought Notice for market research purposes only and does not constitute a solicitation. Responses will not be evaluated competitively and will not result in a contract award. Respondents will not be reimbursed for costs incurred.